PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ascentage Pharma (SUZHOU) Co., Ltd.

USPTO PatentsView assignee record - 30 granted patents across 10 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ascentage ranks #10,256 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 10 technology areas.

#10,256
of 49,997 US assignees by volume
Top 10%
by Innovation Score (52.8/100)
16.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R10256 · Foreign Corporation #10,256 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,256/49,997
  • PHOTO-FINISH AcuFocus
  • CPC-FOCUS A61P · 10 areas
  • INNOV-PAR 52.8/100
  • CLAIMS-RICH 16.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: AcuFocus, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ascentage’s 52.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ascentage

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ascentage's Innovation Score is 52.8/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ascentage?

Each dot is one of Ascentage’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ascentage’s own 16.2 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ascentage vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 510152025 Granted patents (volume) Avg claims / patent Amulaire Thermal Technology, Inc. - 30, 8.73Amulaire Thermal…Aputure Imaging Industries Co., Ltd. - 30, 15.2Aputure Imaging I…Ardisam, Inc. - 30, 17.87ArdisamArlanxeo Singapore PTE. Ltd. - 30, 18.67Arlanxeo Singapor…Asus Technology Licensing Inc. - 30, 17.43Asus Technology L…Azurewave Technologies, Inc. - 30, 7.73AzurewaveAcuFocus, Inc. - 30, 18AcufocusAdaptive Computing Enterprises, Inc. - 30, 19.87Adaptive Computin…Ascentage Pharma (SUZHOU) Co., Ltd. - 30, 16.23Ascentage Pharma…
Ascentage vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ascentage's grants concentrate

Ascentage Pharma (SUZHOU) Co., Ltd. is a focused PatentsView assignee: 10 CPC subclasses with 86.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (11 grants) versus a trough of 4 in 2023. By volume, Ascentage sits between Amulaire Thermal Technology, Inc. and Adaptive Computing Enterprises, Inc..

Ascentage's three-year grant acceleration

Ascentage Pharma (SUZHOU) Co., Ltd. shows 20 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Ascentage's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Ascentage holds 30 patents at rank #10,248, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Ascentage

By rank, the assignees closest to #10,248 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Ascentage's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ascentage, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Ascentage ranks #760 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Savannah River Nuclear Solutions, LLC 53 Varian Medical Systems International AG 53 NextInput, Inc. 53 Montana State University 53

Ascentage's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

24681012 2022202320242025 10
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Ascentage Pharma (SUZHOU) Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 11 36.7%
2023 4 13.3%
2024 5 16.7%
2025partial year 10 33.3%

Which technologies does Ascentage Pharma (SUZHOU) Co., Ltd. patent most?

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ascentage Pharma (SUZHOU) Co., Ltd.'s patent record in context - here's where to go next.

  • Ascentage Pharma (SUZHOU) Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 86.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #10,256 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Ascentage Pharma (SUZHOU) Co., Ltd. against Amulaire Thermal Technology, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.